Aim: Despite the serious side effects, analgesics acting on opioid receptors are still considered the best way to get antinociception. Matrix metalloproteinases, a large family of zinc-dependent proteases implicated in many pathological conditions, such as diabetes and osteoarthritis, are also involved in inflammation and pain. Methodology & results: Looking for evidence of possible interactions of opioid pathways and inflammation mediators, molecular modeling studies of a series of recently developed μ-opioid receptor benzomorphanic agonists together with biological data on pain and inflammation molecular targets, al- lowed us to hypothesize a possible correlation between μ-opioid receptor system and MMP-9. Conclusion: A new compound, (-)-MML1017, emerged as a possible dual-acting agent able to interact selectively and potently with the two molecular targets.

Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors

Simone Ronsisvalle
Conceptualization
;
Angelo Spadaro
Membro del Collaboration Group
;
Barbara Tomasello
Membro del Collaboration Group
;
Livia Basile
Membro del Collaboration Group
;
Silvia Franchini
Membro del Collaboration Group
;
Marcella Renis
Membro del Collaboration Group
;
Salvatore Guccione
Membro del Collaboration Group
;
Lucia Crascı`
Membro del Collaboration Group
;
Anna Maria Panico
Membro del Collaboration Group
2019

Abstract

Aim: Despite the serious side effects, analgesics acting on opioid receptors are still considered the best way to get antinociception. Matrix metalloproteinases, a large family of zinc-dependent proteases implicated in many pathological conditions, such as diabetes and osteoarthritis, are also involved in inflammation and pain. Methodology & results: Looking for evidence of possible interactions of opioid pathways and inflammation mediators, molecular modeling studies of a series of recently developed μ-opioid receptor benzomorphanic agonists together with biological data on pain and inflammation molecular targets, al- lowed us to hypothesize a possible correlation between μ-opioid receptor system and MMP-9. Conclusion: A new compound, (-)-MML1017, emerged as a possible dual-acting agent able to interact selectively and potently with the two molecular targets.
drug discovery • inflammation • MMP-9 inhibitors • molecular modeling • MOR agonists • multitarget drugs • pain
File in questo prodotto:
File Dimensione Formato  
Ronsisvalle FutureMedChem.pdf

non disponibili

Descrizione: FutureMedChem 2019
Tipologia: Versione Editoriale (PDF)
Dimensione 7.17 MB
Formato Adobe PDF
7.17 MB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/363766
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact